DOCSLIB.ORG

Gene Expression Studies in Depression Development and Treatment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Mariani et al. Translational Psychiatry (2021) 11:354 https://doi.org/10.1038/s41398-021-01469-6 Translational Psychiatry REVIEW ARTICLE Open Access Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers Nicole Mariani 1, Nadia Cattane2,CarminePariante 1 and Annamaria Cattaneo 2,3 Abstract A combination of different risk factors, such as genetic, environmental and psychological factors, together with immune system, stress response, brain neuroplasticity and the regulation of neurotransmitters, is thought to lead to the development of major depressive disorder (MDD). A growing number of studies have tried to investigate the underlying mechanisms of MDD by analysing the expression levels of genes involved in such biological processes. These studies have shown that MDD is not just a brain disorder, but also a body disorder, and this is mainly due to the interplay between the periphery and the Central Nervous System (CNS). To this purpose, most of the studies conducted so far have mainly dedicated to the analysis of the gene expression levels using postmortem brain tissue as well as peripheral blood samples of MDD patients. In this paper, we reviewed the current literature on candidate gene expression alterations and the few existing transcriptomics studies in MDD focusing on inflammation, neuroplasticity, neurotransmitters and stress-related genes. Moreover, we focused our attention on studies, which have investigated 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; mRNA levels as biomarkers to predict therapy outcomes. This is important as many patients do not respond to antidepressant medication or could experience adverse side effects, leading to the interruption of treatment. Unfortunately, the right choice of antidepressant for each individual still remains largely a matter of taking an educated guess. Introduction fact, for instance, environmental factors, such as stressful Major depressive disorder (MDD) is a complex psy- and traumatic events, can affect not only biological sys- chiatric disorder characterized by low mood, anhedonia, tems restricted to the brain, but also pathophysiological feelings of guilt or low self-worth, disturbed sleep or pathways within the entire body4,5. Well-established appetite, low energy and suicidal ideation1,2. It is one of evidence suggests deregulation in the inflammatory the main causes of disability worldwide and is a major response, in the hypothalamus-pituitary-adrenal (HPA) contributor to the overall global burden of disease3. axis and in several neuronal systems in the pathogenesis The combination of genetic, environmental and psy- of MDD6,7. As such, acute and chronic stress have been chological factors is believed to be the cause of MDD. In proposed to trigger the dysregulation of these systems and to lead to the development of MDD8. Hence, biological systems such as immune system, stress response, brain Correspondence: Annamaria Cattaneo ([email protected]) 1Stress, Psychiatry and Immunology Laboratory, Department of Psychological neuroplasticity and the regulation of neurotransmitters Medicine, Institute of Psychiatry, Psychology & Neuroscience, King’s College seem to be the ones more involved in MDD. London, London, UK To date, different approaches have been used to 2IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Biological Psychiatry Laboratory, Brescia, Italy understand the molecular mechanisms underlying MDD. Full list of author information is available at the end of the article © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Mariani et al. Translational Psychiatry (2021) 11:354 Page 2 of 23 Among the others, gene expression is being used in a diseases, with MDD, suggesting a very strong relationship large number of studies to analyse the expression of between inflammation and MDD18,19. However, although dozens of genes in MDD. it is well known that depression can influence immune To this purpose, most of the studies conducted so far responses and vice versa, the underlying molecular have mainly investigated the gene expression levels using mechanisms are still unclear. postmortem brain tissue9 as well as peripheral blood Among all the molecules involved in the immune samples of MDD patients. While the use of brain tissue is response, cytokines, known as chemical messengers limited and has several limitations due to the influence of between immune cells, represent the most important key agonal and postmortem factors on gene expression players in mediating depressive symptoms. They include levels10, the use of peripheral blood samples seems to various groups of molecules produced, upon stimulation have multiple advantages. Indeed, peripheral blood by pathogens or dysfunctional cells, by immune cells of samples allow to collect large sample sizes, to obtain a the periphery as well as cells of the central nervous system fast RNA stabilization, as well as the isolation of specific such as microglia, astrocytes, oligodendrocytes. Moreover, cell subtypes, such as peripheral blood mononuclear also neurons can release cytokines and chemokines as cells (PBMCs) or leukocytes and to monitor the patients’ well as respond to them through cytokine and chemokine well-being. receptors20. The association between the brain and the periphery For this reason, also taking into account that cytokines has been demonstrated several years ago by Sullivan and can cross the blood–brain barrier21, they may represent a colleagues11, who have shown genes shared among whole potentially useful biomarker resource relating to mood blood and 16 brain tissues, where 60% of transcripts were disorders. expressed in the whole blood and in at least one tissue of Several components of the immune system, including the central nervous system (CNS). In detail, both whole the Toll-like receptors (TLRs), their intracellular signaling blood and brain tissues have similar expression of genes molecules and their related pro-inflammatory transcrip- relevant to MDD such as genes encoding for neuro- tion factors such as nuclear factor kappa-light-chain- transmitter receptors and transporters, growth factors, enhancer of activated B cells (NF-kB) and interferon hormones and cytokines. In addition to these data, tran- regulatory transcription factor 3 (IRF3) play crucial roles scriptional profiling in peripheral blood has allowed the in the production of pro-inflammatory cytokines, discovery of possible biomarkers for patients with psy- including Interleukin (IL)-1b and IL-1822. chiatric and neurological disorders including patients To investigate the role of inflammation in MDD, several – affected by MDD12 14. studies available so far have measured the mRNA levels of Based on this, we reviewed the current literature on genes involved in inflammation in the peripheral blood candidate gene expression in MDD, mainly focusing on and postmortem brain tissues of patients with MDD (see genes related to inflammation, neuroplasticity, neuro- Table 1). For example, the study conducted by Rizavi et al. transmitters, stress response and treatment outcomes. We in 201623 indicated an increased expression of pro- have also included a few existing transcriptomics studies, inflammatory cytokines and their receptors in the lym- which identified changes in gene expression levels by phocytes of depressed patients as compared to control using a hypothesis-free approach. subjects, proposing an abnormal expression not only of Blood gene expression alterations in MDD have been genes encoding for pro-inflammatory cytokines, but also already reviewed in 201315 by our group. Although in the of genes encoding for their membrane-bound receptors in paper by Hepgul et al. we focused on inflammation, GR MDD. Moreover, Momeni et al.24 showed higher mRNA functionality and neuroplasticity, we did not report gene levels of an adaptor protein (ASC), correlated with absent expression studies in relation to treatment outcome. Since in melanoma 2 (AIM2) gene, in peripheral blood of in these last years a large body of studies has investigated depressed patients. AIM2 is a component of inflamma- gene expression alterations in association with MDD from somes, which can trigger caspase-1 via ASC following a 2013 to date, also including treatment outcomes, we have pathogen-associated molecular pattern (PAMP) or seen the need for a more up-to-date review. danger-associated molecular pattern (DAMP) recogni- tion. Therefore, the activation of caspase-1 can trigger the Inflammation-related genes induction of IL-1 and IL-18, two important pro- In recent years, several studies have suggested an inflammatory cytokines. Similarly, the Genome-Based
Recommended publications
  • Four Unique Interneuron Populations Reside in Neocortical Layer 1

    Four Unique Interneuron Populations Reside in Neocortical Layer 1

    The Journal of Neuroscience, January 2, 2019 • 39(1):125–139 • 125 Systems/Circuits Four Unique Interneuron Populations Reside in Neocortical Layer 1 X Benjamin Schuman,1* XRobert P. Machold,1* Yoshiko Hashikawa,1 Ja´nos Fuzik,1 Gord J. Fishell,2 and X Bernardo Rudy1,3 1Neuroscience Institute, New York University, New York, New York 10016, 2Harvard Medical School and the Stanley Center at the Broad, Cambridge, Massachusetts 02142, and 3Department of Anesthesiology, Perioperative Care and Pain Medicine, New York University School of Medicine, New York, New York 10016 Sensory perception depends on neocortical computations that contextually adjust sensory signals in different internal and environmen- tal contexts. Neocortical layer 1 (L1) is the main target of cortical and subcortical inputs that provide “top-down” information for context-dependent sensory processing. Although L1 is devoid of excitatory cells, it contains the distal “tuft” dendrites of pyramidal cells (PCs) located in deeper layers. L1 also contains a poorly characterized population of GABAergic interneurons (INs), which regulate the impact that different top-down inputs have on PCs. A poor comprehension of L1 IN subtypes and how they affect PC activity has hampered our understanding of the mechanisms that underlie contextual modulation of sensory processing. We used novel genetic strategies in male and female mice combined with electrophysiological and morphological methods to help resolve differences that were unclear when using only electrophysiological and/or morphological approaches. We discovered that L1 contains four distinct popula- tions of INs, each with a unique molecular profile, morphology, and electrophysiology, including a previously overlooked IN population (named here “canopy cells”) representing 40% of L1 INs.
  • Original Article Upregulation of HOXA13 As a Potential Tumorigenesis and Progression Promoter of LUSC Based on Qrt-PCR and Bioinformatics

    Original Article Upregulation of HOXA13 As a Potential Tumorigenesis and Progression Promoter of LUSC Based on Qrt-PCR and Bioinformatics

    Int J Clin Exp Pathol 2017;10(10):10650-10665 www.ijcep.com /ISSN:1936-2625/IJCEP0065149 Original Article Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics Rui Zhang1*, Yun Deng1*, Yu Zhang1, Gao-Qiang Zhai1, Rong-Quan He2, Xiao-Hua Hu2, Dan-Ming Wei1, Zhen-Bo Feng1, Gang Chen1 Departments of 1Pathology, 2Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. *Equal contributors. Received September 7, 2017; Accepted September 29, 2017; Epub October 1, 2017; Published October 15, 2017 Abstract: In this study, we investigated the levels of homeobox A13 (HOXA13) and the mechanisms underlying the co-expressed genes of HOXA13 in lung squamous cancer (LUSC), the signaling pathways in which the co-ex- pressed genes of HOXA13 are involved and their functional roles in LUSC. The clinical significance of 23 paired LUSC tissues and adjacent non-tumor tissues were gathered. HOXA13 levels in LUSC were detected by quantita- tive real-time polymerase chain reaction (qRT-PCR). HOXA13 levels in LUSC from The Cancer Genome Atlas (TCGA) and Oncomine were analyzed. We performed receiver operator characteristic (ROC) curves of various clinicopath- ological features of LUSC. Co-expressed of HOXA13 were collected from MEM, cBioPortal and GEPIA. The func- tions and pathways of the most reliable overlapped genes were achieved from the Gene Otology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. The protein-protein interaction (PPI) net- works were mapped using STRING. HOXA13 in LUSC were markedly upregulated compared with those in the non- cancerous controls as demonstrated by qRT-PCR (LUSC: 0.330±0.360; CONTROLS: 0.155±0.142; P=0.021).
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia

    1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia

    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
  • Thyroid Hormone Influences Brain Gene Expression Programs And

    Thyroid Hormone Influences Brain Gene Expression Programs And

    Molecular Psychiatry https://doi.org/10.1038/s41380-018-0281-4 ARTICLE Thyroid hormone influences brain gene expression programs and behaviors in later generations by altering germ line epigenetic information 1 2,3 1 1 1 M. Elena Martinez ● Christine W. Duarte ● J. Patrizia Stohn ● Aldona Karaczyn ● Zhaofei Wu ● 1 1,3,4 Victoria E DeMambro ● Arturo Hernandez Received: 30 March 2018 / Revised: 16 August 2018 / Accepted: 26 September 2018 © Springer Nature Limited 2018 Abstract Genetic factors do not fully account for the relatively high heritability of neurodevelopmental conditions, suggesting that non-genetic heritable factors contribute to their etiology. To evaluate the potential contribution of aberrant thyroid hormone status to the epigenetic inheritance of neurological phenotypes, we examined genetically normal F2 generation descendants of mice that were developmentally overexposed to thyroid hormone due to a Dio3 mutation. Hypothalamic gene expression profiling in postnatal day 15 F2 descendants on the paternal lineage of ancestral male and female T3-overexposed mice 1234567890();,: 1234567890();,: revealed, respectively, 1089 and 1549 differentially expressed genes. A large number of them, 675 genes, were common to both sets, suggesting comparable epigenetic effects of thyroid hormone on both the male and female ancestral germ lines. Oligodendrocyte- and neuron-specific genes were strongly overrepresented among genes showing, respectively, increased and decreased expression. Altered gene expression extended to other brain regions and was associated in adulthood with decreased anxiety-like behavior, increased marble burying and reduced physical activity. The sperm of T3-overexposed male ancestors revealed significant hypomethylation of CpG islands associated with the promoters of genes involved in the early development of the central nervous system.
  • NMDA Receptor Dynamics Dictate Neuronal Plasticity and Function

    NMDA Receptor Dynamics Dictate Neuronal Plasticity and Function

    NMDA Receptor Dynamics Dictate Neuronal Plasticity and Function Tommy Weiss Sadan, Ph.D. and Melanie R. Grably, Ph.D. N-Methyl-D-Aspartate Receptor (NMDAR) are ubiquitously expressed along the central nervous system and are instrumental to various physiological processes such as synaptic plasticity and learning. Nevertheless, several mental disabilities including schizophrenia and Alzheimer’s disease are all related to NMDAR dysfunction. Here, we review many aspects of NMDAR function and regulation and describe their involvement in pathophysiological states using Alomone Labs products. Right: Cell surface detection of GluN2B in rat hippocampal neurons. Introduction Mechanism of Action Glutamate is a key neuro-transmitter in the central nervous system and NMDAR activation depends on sequential conformational changes to acts on a variety of cell surface receptors, collectively termed ionotropic relieve the magnesium blockade which is achieved by rapid membrane glutamate receptors (iGluRs)15. The N-Methyl-D-Aspartate receptors (NMDAR) depolarization and binding of both glycine and glutamate ligands6, 21. This in are members of the iGluR superfamily and are pivotal to many physiological turn removes the inhibitory electrostatic forces of magnesium and enables processes such as the formation of long term memory, synaptic plasticity calcium influx and transmission of long lasting signals (i.e. long-term and many other cognitive functions. Therefore, it is not surprising that potentiation), a key mechanism to learning and memory formation10.
  • Anti-GRIK1 / Glur5 Antibody (ARG59676)

    Anti-GRIK1 / Glur5 Antibody (ARG59676)

    Product datasheet [email protected] ARG59676 Package: 50 μg anti-GRIK1 / GluR5 antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes GRIK1 / GluR5 Tested Reactivity Hu, Ms, Rat Tested Application IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name GRIK1 / GluR5 Species Human Immunogen Recombinant protein corresponding to R271-I450 of Human GRIK1. Conjugation Un-conjugated Alternate Names GluR5; GluK1; GLUR5; EEA3; GluR-5; Excitatory amino acid receptor 3; Glutamate receptor ionotropic, kainate 1; EAA3; Glutamate receptor 5; GLR5 Application Instructions Application table Application Dilution IHC-P 1:200 - 1:1000 WB 0.1 - 0.5 µg/ml Application Note IHC-P: Antigen Retrieval: Heat mediation was performed in Citrate buffer (pH 6.0) for 20 min. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Properties Form Liquid Purification Affinity purification with immunogen. Buffer 0.9% NaCl, 0.2% Na2HPO4, 0.05% Sodium azide and 5% BSA. Preservative 0.05% Sodium azide Stabilizer 5% BSA Concentration 0.5 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/4 Bioinformation Gene Symbol GRIK1 Gene Full Name glutamate receptor, ionotropic, kainate 1 Background Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes.
  • Chr21 Protein-Protein Interactions: Enrichment in Products Involved in Intellectual Disabilities, Autism and Late Onset Alzheimer Disease

    Chr21 Protein-Protein Interactions: Enrichment in Products Involved in Intellectual Disabilities, Autism and Late Onset Alzheimer Disease

    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.11.872606; this version posted December 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Chr21 protein-protein interactions: enrichment in products involved in intellectual disabilities, autism and Late Onset Alzheimer Disease Julia Viard1,2*, Yann Loe-Mie1*, Rachel Daudin1, Malik Khelfaoui1, Christine Plancon2, Anne Boland2, Francisco Tejedor3, Richard L. Huganir4, Eunjoon Kim5, Makoto Kinoshita6, Guofa Liu7, Volker Haucke8, Thomas Moncion9, Eugene Yu10, Valérie Hindie9, Henri Bléhaut11, Clotilde Mircher12, Yann Herault13,14,15,16,17, Jean-François Deleuze2, Jean- Christophe Rain9, Michel Simonneau1, 18, 19, 20** and Aude-Marie Lepagnol- Bestel1** 1 Centre Psychiatrie & Neurosciences, INSERM U894, 75014 Paris, France 2 Laboratoire de génomique fonctionnelle, CNG, CEA, Evry 3 Instituto de Neurociencias CSIC-UMH, Universidad Miguel Hernandez-Campus de San Juan 03550 San Juan (Alicante), Spain 4 Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA 5 Center for Synaptic Brain Dysfunctions, Institute for Basic Science, Daejeon 34141, Republic of Korea 6 Department of Molecular Biology, Division of Biological Science, Nagoya University Graduate School of Science, Furo, Chikusa, Nagoya, Japan 7 Department of Biological Sciences, University of Toledo, Toledo, OH, 43606, USA 8 Leibniz Forschungsinstitut für Molekulare Pharmakologie
  • Serotonin Receptor 3A Controls Interneuron Migration Into the Neocortex

    Serotonin Receptor 3A Controls Interneuron Migration Into the Neocortex

    ARTICLE Received 3 Sep 2014 | Accepted 9 Oct 2014 | Published 20 Nov 2014 DOI: 10.1038/ncomms6524 OPEN Serotonin receptor 3A controls interneuron migration into the neocortex Sahana Murthy1,2,*, Mathieu Niquille1,2,*, Nicolas Hurni1,2, Greta Limoni1,2, Sarah Frazer1,2, Pascal Chameau3, Johannes A. van Hooft3, Tania Vitalis4 & Alexandre Dayer1,2 Neuronal excitability has been shown to control the migration and cortical integration of reelin-expressing cortical interneurons (INs) arising from the caudal ganglionic eminence (CGE), supporting the possibility that neurotransmitters could regulate this process. Here we show that the ionotropic serotonin receptor 3A (5-HT3AR) is specifically expressed in CGE-derived migrating interneurons and upregulated while they invade the developing cortex. Functional investigations using calcium imaging, electrophysiological recordings and migra- tion assays indicate that CGE-derived INs increase their response to 5-HT3AR activation during the late phase of cortical plate invasion. Using genetic loss-of-function approaches and in vivo grafts, we further demonstrate that the 5-HT3AR is cell autonomously required for the migration and proper positioning of reelin-expressing CGE-derived INs in the neocortex. Our findings reveal a requirement for a serotonin receptor in controlling the migration and laminar positioning of a specific subtype of cortical IN. 1 Department of Mental Health and Psychiatry, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland. 2 Department of Basic Neurosciences, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland. 3 Swammerdam Institute for Life Sciences, Center for NeuroScience, University of Amsterdam, Sciencepark 904, 1098 XH Amsterdam, The Netherlands. 4 CNRS-UMR 8249, Brain Plasticity Unit, ESPCI ParisTech, 10 rue Vauquelin, 75005 Paris, France.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • High Yield and Efficient Expression and Purification of the Human 5-HT3A Receptor

    High Yield and Efficient Expression and Purification of the Human 5-HT3A Receptor

    npg Acta Pharmacologica Sinica (2015) 36: 1024–1032 © 2015 CPS and SIMM All rights reserved 1671-4083/15 www.nature.com/aps Original Article High yield and efficient expression and purification of the human 5-HT3A receptor Zhong-shan WU1, 2, Zhi-cheng CUI3, Hao CHENG2, Chen FAN3, Karsten MELCHER4, Yi JIANG2, Cheng-hai ZHANG2, Hua-liang JIANG5, Yao CONG2, Qian LIU1, *, H Eric XU2, 4, * 1Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430074, China; 2VARI-SIMM Center, Center for Structure and Function of Drug Targets, CAS-Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; 3National Center for Protein Science Shanghai, State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 201210, China; 4Laboratory of Structural Sciences, Van Andel Research Institute, Grand Rapids, MI 49503, USA; 5State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China Aim: To establish a method for efficient expression and purification of the human serotonin type 3A receptor (5-HT3A) that is suitable for structural studies. Methods: Codon-optimized cDNA of human 5-HT3A was inserted into a modified BacMam vector, which contained an IgG leader sequence, an 8×His tag linked with two-Maltose Binding Proteins (MBP), and a TEV protease cleavage site. The BacMam construct was used to generate baculoviruses for expression of 5-HT3A in HEK293F cells. The proteins were solubilized from the membrane with the detergent C12E9, and purified using MBP affinity chromatography.
  • Sex Differences in Glutamate Receptor Gene Expression in Major Depression and Suicide

    Sex Differences in Glutamate Receptor Gene Expression in Major Depression and Suicide

    Molecular Psychiatry (2015) 20, 1057–1068 © 2015 Macmillan Publishers Limited All rights reserved 1359-4184/15 www.nature.com/mp IMMEDIATE COMMUNICATION Sex differences in glutamate receptor gene expression in major depression and suicide AL Gray1, TM Hyde2,3, A Deep-Soboslay2, JE Kleinman2 and MS Sodhi1,4 Accumulating data indicate that the glutamate system is disrupted in major depressive disorder (MDD), and recent clinical research suggests that ketamine, an antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor (GluR), has rapid antidepressant efficacy. Here we report findings from gene expression studies of a large cohort of postmortem subjects, including subjects with MDD and controls. Our data reveal higher expression levels of the majority of glutamatergic genes tested in the dorsolateral prefrontal cortex (DLPFC) in MDD (F21,59 = 2.32, P = 0.006). Posthoc data indicate that these gene expression differences occurred mostly in the female subjects. Higher expression levels of GRIN1, GRIN2A-D, GRIA2-4, GRIK1-2, GRM1, GRM4, GRM5 and GRM7 were detected in the female patients with MDD. In contrast, GRM5 expression was lower in male MDD patients relative to male controls. When MDD suicides were compared with MDD non-suicides, GRIN2B, GRIK3 and GRM2 were expressed at higher levels in the suicides. Higher expression levels were detected for several additional genes, but these were not statistically significant after correction for multiple comparisons. In summary, our analyses indicate a generalized disruption of the regulation of the GluRs in the DLPFC of females with MDD, with more specific GluR alterations in the suicides and in the male groups.
  • Supplementary Material

    Supplementary Material

    Supplementary Material Table S1: Significant downregulated KEGGs pathways identified by DAVID following exposure to five cinnamon- based phenylpropanoids (p < 0.05). p-value Term: Genes (Benjamini) Cytokine-cytokine receptor interaction: FASLG, TNFSF14, CXCL11, IL11, FLT3LG, CCL3L1, CCL3L3, CXCR6, XCR1, 2.43 × 105 RTEL1, CSF2RA, TNFRSF17, TNFRSF14, CCNL2, VEGFB, AMH, TNFRSF10B, INHBE, IFNB1, CCR3, VEGFA, CCR2, IL12A, CCL1, CCL3, CXCL5, TNFRSF25, CCR1, CSF1, CX3CL1, CCL7, CCL24, TNFRSF1B, IL12RB1, CCL21, FIGF, EPO, IL4, IL18R1, FLT1, TGFBR1, EDA2R, HGF, TNFSF8, KDR, LEP, GH2, CCL13, EPOR, XCL1, IFNA16, XCL2 Neuroactive ligand-receptor interaction: OPRM1, THRA, GRIK1, DRD2, GRIK2, TACR2, TACR1, GABRB1, LPAR4, 9.68 × 105 GRIK5, FPR1, PRSS1, GNRHR, FPR2, EDNRA, AGTR2, LTB4R, PRSS2, CNR1, S1PR4, CALCRL, TAAR5, GABRE, PTGER1, GABRG3, C5AR1, PTGER3, PTGER4, GABRA6, GABRA5, GRM1, PLG, LEP, CRHR1, GH2, GRM3, SSTR2, Chlorogenic acid Chlorogenic CHRM3, GRIA1, MC2R, P2RX2, TBXA2R, GHSR, HTR2C, TSHR, LHB, GLP1R, OPRD1 Hematopoietic cell lineage: IL4, CR1, CD8B, CSF1, FCER2, GYPA, ITGA2, IL11, GP9, FLT3LG, CD38, CD19, DNTT, 9.29 × 104 GP1BB, CD22, EPOR, CSF2RA, CD14, THPO, EPO, HLA-DRA, ITGA2B Cytokine-cytokine receptor interaction: IL6ST, IL21R, IL19, TNFSF15, CXCR3, IL15, CXCL11, TGFB1, IL11, FLT3LG, CXCL10, CCR10, XCR1, RTEL1, CSF2RA, IL21, CCNL2, VEGFB, CCR8, AMH, TNFRSF10C, IFNB1, PDGFRA, EDA, CXCL5, TNFRSF25, CSF1, IFNW1, CNTFR, CX3CL1, CCL5, TNFRSF4, CCL4, CCL27, CCL24, CCL25, CCL23, IFNA6, IFNA5, FIGF, EPO, AMHR2, IL2RA, FLT4, TGFBR2, EDA2R,